Amit Singla, MD
Neurological Surgery · Newark, NJNPI 1720288244
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (41.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Medical Device Business Services, Inc. accounts for 65.6% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $6,731 and has fallen 96.8% since, to $213 in 2024.
Across 38 payments — averaging $235.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$6K
- Medtronic$2K
- Stryker$662
- Rapid Medical Ltd$189
- Qapel Medical Inc$140
- Globus Medical$135
- plus $205 from 3 others
Across 3 payments — averaging $31,821 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boehringer Ingelheim$95K
What the payments were for
- Consulting fees$3,74942%
- Travel & lodging$3,19136%
- Food & beverage$2,02223%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 4 | $5,879 |
| Medtronic(2 entities) | 19 | $1,752 |
| Stryker | 8 | $662 |
| Rapid Medical Ltd | 1 | $189 |
| Qapel Medical Inc | 1 | $140 |
| Globus Medical | 2 | $135 |
| Edwards Lifesciences | 1 | $119 |
| Baxter Healthcare | 1 | $60 |
| Johnson & Johnson | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,962 in reported general payments places this provider in the 70th percentile of 174 neurological surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 11 | $259 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Newark
- Robert HearyNewark$1M
- John GillickNewark$90K
- Michael SchulderNewark$55K
- Antonios MammisNewark$44K
- Chirag GandhiNewark$16K
- Harshpal SinghHackensack$677K
- Ira GoldsteinMontclair$344K
- Karthik MadhavanCherry Hill$291K
- Simon SalernoWall Township$275K
- Shabbar DanishNeptune$267K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.